Literature DB >> 26458287

Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Eva L Feldman1, Richard A C Hughes2, Hugh J Willison3.   

Abstract

The past quarter of a century has brought incredible advances in our understanding of inflammatory neuropathies, and the insights into Guillain-Barré syndrome (GBS) began in the 1990s with the seminal work of Dr Jack Griffin and his colleagues. In this essay, we provide a tribute to Jack, and review the recent progress in a field that he termed his personal favourite. In particular, we discuss the new developments in our understanding and diagnosis of inflammatory neuropathies, the recent emergence of the node of Ranvier and the paranode as sites of intensive investigation, and the mechanistic evidence that is providing a platform for therapeutic development studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26458287     DOI: 10.1038/nrneurol.2015.192

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  58 in total

1.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

2.  Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.

Authors:  Go Ogawa; Ken-ichi Kaida; Susumu Kusunoki; Masami Ueda; Fumihiko Kimura; Keiko Kamakura
Journal:  J Neuroimmunol       Date:  2009-07-24       Impact factor: 3.478

Review 3.  Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Jane Pritchard; Robert D M Hadden
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

4.  Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis.

Authors:  Hugh Willison; Steven S Scherer
Journal:  Neurology       Date:  2014-06-11       Impact factor: 9.910

5.  Prediction of respiratory insufficiency in Guillain-Barré syndrome.

Authors:  Christa Walgaard; Hester F Lingsma; Liselotte Ruts; Judith Drenthen; Rinske van Koningsveld; Marcel J P Garssen; Pieter A van Doorn; Ewout W Steyerberg; Bart C Jacobs
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

6.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

7.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

8.  Patterns of Guillain-Barre syndrome in children: results from a Mexican population.

Authors:  I Nachamkin; P Arzarte Barbosa; P Arzate Barbosa; Huong Ung; H Ung; C Lobato; A Gonzalez Rivera; A Gonzalez Rivera; P Rodriguez; A Garcia Briseno; A Garcia Briseno; L Maria Cordero; L Garcia Perea; L Garcia Perea; J Carlos Perez; M Ribera; P Chico Aldama; G Dávila Guitérrez; L Flores Sarnat; M Ruiz García; J Veitch; C Fitzgerald; D R Cornblath; D Cornblath; M Rodriguez Pinto; M Rodriguez Pinto; J W Griffin; H J Willison; A K Asbury; G M McKhann
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

Review 9.  Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.

Authors:  Jia Pei Lim; Jérôme Devaux; Nobuhiro Yuki
Journal:  Autoimmun Rev       Date:  2014-08-27       Impact factor: 9.754

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  3 in total

Review 1.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Authors:  Eva L Feldman; Klaus-Armin Nave; Troels S Jensen; David L H Bennett
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

Review 2.  Diagnostics of dysimmune peripheral neuropathies.

Authors:  Diego Franciotta; Matteo Gastaldi; Luana Benedetti; Giampaola Pesce; Tiziana Biagioli; Francesco Lolli; Gianna Costa; Cristina Melis; Francesca Andreetta; Ornella Simoncini; Claudia Giannotta; Elena Bazzigaluppi; Raffaella Fazio; Roberta Bedin; Diana Ferraro; Sara Mariotto; Sergio Ferrari; Elisabetta Galloni; Valentina De Riva; Elisabetta Zardini; Andrea Cortese; Eduardo Nobile-Orazio
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

3.  Sensorimotor and pain-related alterations of the gray matter and white matter in Type 2 diabetic patients with peripheral neuropathy.

Authors:  Youming Zhang; Minli Qu; Xiaoping Yi; Pei Zhuo; Jingyi Tang; Xin Chen; Gaofeng Zhou; Ping Hu; Ting Qiu; Wu Xing; Yitao Mao; Bihong T Chen; Jing Wu; Yuanchao Zhang; Weihua Liao
Journal:  Hum Brain Mapp       Date:  2019-10-29       Impact factor: 5.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.